New Russian Ebola Vaccine Targets Bundibugyo Outbreak
Russian health authorities have stepped forward with a newly developed vaccine aimed squarely at the Bundibugyo strain of Ebola that is sweeping through the Democratic Republic of Congo. Health...
Russian health authorities have stepped forward with a newly developed vaccine aimed squarely at the Bundibugyo strain of Ebola that is sweeping through the Democratic Republic of Congo. Health Minister Mikhail Murashko announced the breakthrough, noting that early laboratory data suggest the shot can neutralize the rare variant responsible for the current surge. The WHO raised the alarm on 17 May, classifying the situation as an international public health emergency after confirming 101 cases and ten deaths while suspecting the true toll is significantly higher. Congo’s Health Minister Roger Kamba described the outbreak as still nascent yet rapidly expanding, with nearly one thousand suspected infections already logged. Although the Bundibugyo strain carries a lower fatality rate than the more notorious Zaire variant, officials caution that unchecked spread could overwhelm fragile health systems. The crisis has already crossed into Uganda, where five confirmed cases and one death have been recorded. Russian scientists say the vaccine fills a critical gap because no approved immunization previously existed for this particular strain. International partners are now evaluating how quickly the new formulation can be validated, manufactured, and distributed to frontline responders in both Congo and Uganda.